Vincristine neurotoxicity. Pathophysiology and management.
about
Neuropathic cancer pain: What we are dealing with? How to manage it?Vincristine-induced peripheral neuropathy in pediatric cancer patientsFeasibility and initial effectiveness of home exercise during maintenance therapy for childhood acute lymphoblastic leukemiaManagement of pediatric and adult patients with medulloblastoma.Vincristine-induced polyneuropathy in a child with stage I Wilms' tumour presenting with unilateral abducens nerve palsy.Neostigmine for the treatment of acute colonic pseudo-obstruction (ACPO) in pediatric hematologic malignanciesVincristine-induced unilateral ptosis with serendipitous response to modafinil.Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Impairments that influence physical function among survivors of childhood cancerNeuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses.Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia.Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomesBlockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic Leukemia.Towards novel anti-tumor strategies for hepatic cancer: ɛ-viniferin in combination with vincristine displays pharmacodynamic synergy at lower doses in HepG2 cells.Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.Follicular lymphoma patient relapsing with paraneoplastic sensory neuronopathy (ganglioneuropathy).Anti-allodynic effect of theoesberiven F in a vincristine-induced neuropathy model.Procarbazine, lomustine and vincristine toxicity in low-grade gliomas.Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
P2860
Q26998945-07961F68-55FF-4926-81A1-7B0526CB0AAAQ28078232-9C951FE1-08EE-48E0-A154-5BD461D087D8Q30596383-B06A0432-A850-4332-9037-F891E6D9DFEDQ30847947-E64E37A0-6340-4B08-8F45-17D31575EC96Q33833462-523F05B1-1037-46E4-8337-8C4C99A2B0E2Q34316792-2A39AA0A-D28D-40CC-9DD3-95A2D1F8CAAEQ34951449-EFD33BDC-6660-4BD0-88BD-C1600AB28317Q35076156-A6044F4D-4EFB-4F03-9E3D-83C215D2A22EQ35082766-7C569BD4-638C-4206-A427-5380A736D36FQ35402351-28046801-3C95-4877-9F46-9C051FC87430Q35691002-E961F4FD-62A7-4E96-8DBE-4BCEECAFC30EQ35826566-805CE55D-5CD7-4A51-BD7B-26A65EF8C598Q36106864-B377AF26-DB9D-4D3F-94E3-8B2F859ACA4EQ36310718-43C972B5-876A-4EFB-B4AD-BDADE89E0BD6Q37594508-2ECC5C67-1DBE-4F8C-80D6-AEFCF570BED2Q38796874-BF49FEAC-CE2F-4E4A-9B98-98092399FC9CQ38872343-D51AC882-7666-455F-8EA1-02DA49B867C2Q39294188-705858F1-EAE7-4EB7-92DD-A2EC58E17541Q41483240-0D38FF71-DB27-474E-A171-FCE948427CDFQ41846507-FC414C8E-74B4-4889-AE0A-4AE0BA8122AAQ42413541-F409D2FA-C222-4874-94D0-D2FC59A97162Q55239801-6534E866-138A-4A36-AA74-13CA961DFF55Q58694170-F3D2E8DB-2365-4077-A525-1D48C9EC2A99
P2860
Vincristine neurotoxicity. Pathophysiology and management.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Vincristine neurotoxicity. Pathophysiology and management.
@en
Vincristine neurotoxicity. Pathophysiology and management.
@nl
type
label
Vincristine neurotoxicity. Pathophysiology and management.
@en
Vincristine neurotoxicity. Pathophysiology and management.
@nl
prefLabel
Vincristine neurotoxicity. Pathophysiology and management.
@en
Vincristine neurotoxicity. Pathophysiology and management.
@nl
P356
P1433
P1476
Vincristine neurotoxicity. Pathophysiology and management
@en
P2093
P304
P356
10.1007/BF03259853
P577
1986-11-01T00:00:00Z